Grauer & Weil [GRAUWEIL] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Grauer & Weil (India) Ltd. wins in 14 metrics, Neogen Chemicals Ltd. wins in 6 metrics, with 0 ties. Grauer & Weil (India) Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Grauer & Weil (India) Ltd. | Neogen Chemicals Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.62 | 222.22 | Grauer & Weil (India) Ltd. |
| Price-to-Book Ratio | 3.33 | 5.46 | Grauer & Weil (India) Ltd. |
| Debt-to-Equity Ratio | 1.19 | 141.47 | Grauer & Weil (India) Ltd. |
| PEG Ratio | -0.94 | -3.52 | Grauer & Weil (India) Ltd. |
| EV/EBITDA | 17.16 | 42.55 | Grauer & Weil (India) Ltd. |
| Profit Margin (TTM) | 11.93% | 2.41% | Grauer & Weil (India) Ltd. |
| Operating Margin (TTM) | 11.20% | 11.39% | Neogen Chemicals Ltd. |
| EBITDA Margin (TTM) | 11.20% | 11.39% | Neogen Chemicals Ltd. |
| Return on Equity | 16.74% | 4.41% | Grauer & Weil (India) Ltd. |
| Return on Assets (TTM) | 12.23% | 1.99% | Grauer & Weil (India) Ltd. |
| Free Cash Flow (TTM) | $999.83M | $-1.22B | Grauer & Weil (India) Ltd. |
| Dividend Yield | 1.05% | 0.19% | Grauer & Weil (India) Ltd. |
| 1-Year Return | -13.49% | 10.59% | Neogen Chemicals Ltd. |
| Price-to-Sales Ratio (TTM) | 2.82 | 5.56 | Grauer & Weil (India) Ltd. |
| Enterprise Value | $27.91B | $53.55B | Neogen Chemicals Ltd. |
| EV/Revenue Ratio | 2.37 | 6.55 | Grauer & Weil (India) Ltd. |
| Gross Profit Margin (TTM) | 48.88% | 47.11% | Grauer & Weil (India) Ltd. |
| Revenue per Share (TTM) | $26 | $310 | Neogen Chemicals Ltd. |
| Earnings per Share (Diluted) | $3.10 | $7.47 | Neogen Chemicals Ltd. |
| Beta (Stock Volatility) | 0.13 | 0.22 | Grauer & Weil (India) Ltd. |
Grauer & Weil (India) Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Grauer & Weil (India) Ltd. | -1.92% | -2.78% | 0.57% | 11.05% | -6.09% | -10.07% |
| Neogen Chemicals Ltd. | 1.29% | 6.97% | 12.71% | 39.41% | 74.21% | 61.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Grauer & Weil (India) Ltd. | -13.49% | 30.52% | 169.22% | 408.71% | 2,116.77% | 1,481.26% |
| Neogen Chemicals Ltd. | 10.59% | 19.04% | 106.75% | 609.06% | 609.06% | 609.06% |
Performance & Financial Health Analysis: Grauer & Weil (India) Ltd. vs Neogen Chemicals Ltd.
| Metric | GRAUWEIL | NEOGEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹33.12B | ₹44.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 149,911 | 170,744 |
| 90 Day Avg. Volume | 407,056 | 127,390 |
| Last Close | ₹70.35 | ₹1,901.20 |
| 52 Week Range | ₹49.70 - ₹111.45 | ₹966.70 - ₹1,960.30 |
| % from 52W High | -36.88% | -3.01% |
| All-Time High | ₹204.80 (Feb 26, 2024) | ₹2,420.00 (Dec 09, 2024) |
| % from All-Time High | -65.65% | -21.44% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.09% |
| Quarterly Earnings Growth | -0.25% | -0.63% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.02% |
| Operating Margin (TTM) | 0.11% | 0.11% |
| Return on Equity (TTM) | 0.17% | 0.04% |
| Debt to Equity (MRQ) | 1.19 | 141.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹21.98 | ₹303.78 |
| Cash per Share (MRQ) | ₹10.40 | ₹57.58 |
| Operating Cash Flow (TTM) | ₹1.68B | ₹645.50M |
| Levered Free Cash Flow (TTM) | ₹1.57B | ₹348.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.05% | 0.19% |
| Last 12-Month Dividend | ₹1.00 | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Grauer & Weil (India) Ltd. vs Neogen Chemicals Ltd.
| Metric | GRAUWEIL (Apr 24, 2026) | NEOGEN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.62 | 222.22 |
| Forward P/E | 29.41 | 72.26 |
| PEG Ratio | -0.94 | -3.52 |
| Price to Sales (TTM) | 2.82 | 5.56 |
| Price to Book (MRQ) | 3.33 | 5.46 |
| Market Capitalization | ||
| Market Capitalization | ₹33.12B | ₹44.76B |
| Enterprise Value | ₹27.91B | ₹53.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.37 | 6.55 |
| Enterprise to EBITDA | 17.16 | 42.55 |
| Risk & Other Metrics | ||
| Beta | 0.13 | 0.22 |
| Book Value per Share (MRQ) | ₹21.98 | ₹303.78 |
Financial Statements Comparison: Grauer & Weil (India) Ltd. vs Neogen Chemicals Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | GRAUWEIL (2025) | NEOGEN (2025) |
|---|---|---|
| Revenue/Sales | 10.88B | 7.58B |
| Cost of Goods Sold | 6.32B | 4.44B |
| COGS % of Revenue | 58.1% | 58.6% |
| Gross Profit | 4.56B | 3.13B |
| Gross Margin | 41.9% | 41.4% |
| Research & Development | 33.35M | 11.50M |
| Operating Income (EBIT) | 1.72B | 1.09B |
| Operating Margin | 15.8% | 14.4% |
| EBITDA | 2.29B | 1.31B |
| EBITDA Margin | 21.1% | 17.3% |
| Pre-Tax Income | 2.10B | 501.60M |
| Pre-Tax Income % of Revenue | 19.3% | 6.6% |
| Income Tax | 524.12M | 153.30M |
| Income Tax % of Revenue | 4.8% | 2.0% |
| Net Income (Profit) | 1.57B | 348.30M |
| Profit Margin | 14.4% | 4.6% |
Balance Sheet & Liquidity Metrics
| Metric | GRAUWEIL (2025) | NEOGEN (2025) |
|---|---|---|
| Cash & Equivalents | 1.08B | 49.60M |
| Total Current Assets | 9.36B | 10.00B |
| Total Current Assets % of Revenue | 86.1% | 132.0% |
| Total Current Liabilities | 2.97B | 7.33B |
| Total Current Liabilities % of Revenue | 27.3% | 96.8% |
| Long-Term Debt | 37.36M | 1.94B |
| Long-Term Debt % of Revenue | 0.3% | 25.6% |
| Total Shareholders Equity | 9.39B | 7.89B |
| Retained Earnings | 283.32M | 2.28B |
| Retained Earnings % of Revenue | 2.6% | 30.1% |
| Property, Plant & Equipment | 211.61M | 890.30M |
Cash Flow Statement Comparison
| Metric | GRAUWEIL (2025) | NEOGEN (2025) |
|---|---|---|
| Operating Cash Flow | 1.68B | 645.50M |
| Operating Cash Flow % of Revenue | 15.5% | 8.5% |
| Capital Expenditures | -387.50M | -3.17B |
| Free Cash Flow | 999.83M | -1.22B |
| FCF Margin | 9.2% | -16.1% |
| Debt Repayment | N/A | -718.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GRAUWEIL | NEOGEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 453.41M | 27.38M |
| Float Shares | 128.00M | 13.28M |
| % Held by Insiders | 71.37% | 53.98% |
| % Held by Institutions | 0.18% | 23.81% |
| % Held by Public | 28.45% | 22.21% |
Dividend Analysis & Yield Comparison: Grauer & Weil (India) Ltd. vs Neogen Chemicals Ltd.
| Metric | GRAUWEIL | NEOGEN |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | ₹3.00 |
| Last 12-Month Dividend Yield | 1.05% | 0.19% |
| 3-Year Avg Annual Dividend | ₹0.58 | ₹2.00 |
| 3-Year Avg Dividend Yield | 0.45% | 0.11% |
| 3-Year Total Dividends | ₹1.73 | ₹6.00 |
| Ex-Dividend Date | Aug 06, 2025 | Sep 19, 2025 |